Business ❯ Finance ❯ Corporate Governance ❯ Investor Relations

Shareholder Actions

ImmunityBio Investors Face May 26 Deadline in Securities Class Action Over FDA Ad Rebuke

The case turns on claims that Anktiva promotions misled patients as well as investors.

ScottsMiracle‑Gro Beats Q2 Targets, Expands Margins, Launches Major Share Buyback

Eos Energy Hit With Securities Class Actions After Revenue Miss Triggers 39% Stock Drop

Papa John’s Weighs $47-a-Share Take-Private Bid From Irth Capital